Medicare Heavily Overpaid For Infusion Drugs, Report Says
The U.S. Department of Health and Human Services Office of Inspector General on Wednesday said the agency's mandated Medicare Part B payment policy for infusion drugs had resulted in massive overpayments,...To view the full article, register now.
Already a subscriber? Click here to view full article